Ovid Therapeutics Inc.
OVID
$0.3383
-$0.0117-3.34%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.25M | -14.01M | 8.52M | -11.69M | -15.32M |
| Total Depreciation and Amortization | 160.00K | 169.00K | 148.00K | 136.00K | 140.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -62.00K | 575.00K | -27.11M | -3.39M | -383.00K |
| Change in Net Operating Assets | -853.00K | -1.75M | 4.19M | -1.74M | 3.65M |
| Cash from Operations | -10.01M | -15.01M | -14.26M | -16.69M | -11.91M |
| Capital Expenditure | -22.00K | 4.00K | -34.00K | -19.00K | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.31M | 288.00K | 12.86M | 20.21M | -48.50M |
| Cash from Investing | 21.29M | 292.00K | 12.82M | 20.19M | -48.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 38.00K | 356.00K | 228.00K | 33.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 30.00M |
| Cash from Financing | 0.00 | 38.00K | 356.00K | 228.00K | 30.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -1.00K | 1.00K | 0.00 |
| Net Change in Cash | 11.28M | -14.68M | -1.08M | 3.73M | -30.39M |